Navigation Links
Bionovo Releases FDA-Approved Clinical Development Plan for Menerba
Date:12/13/2010

EMERYVILLE, Calif., Dec. 13, 2010 /PRNewswire-FirstCall/ -- Bionovo, Inc. (Nasdaq: BNVI), a pharmaceutical company focused on the discovery and development of innovative treatments for women's health and cancer, today announced that it had received the minutes from the U.S. Food and Drug Administration's (FDA) Clinical Guidance meeting that took place on November 8, 2010. In that meeting, the FDA agreed with the Company's proposed overall clinical development plan.

"We had a very positive meeting with the FDA to discuss the clinical program for Menerba. The Agency agreed with our overall clinical and non- clinical development plan for approval. The Agency did suggest a change to the clinical development plan which will allow for faster and more efficient initiation of the pivotal testing, by introducing a small Phase 1 study before the first Phase 3 study, which includes a dose 3 times higher than previously tested in the Phase 2," said Mary Tagliaferri, M.D., Bionovo's President and Chief Medical Officer.

"In order to reach higher efficacy we are evaluating the higher dose of Menerba in the first Phase 3 trial. The FDA would like to see additional safety data to assess this dose. We had originally proposed to the FDA to use the first 60 patients enrolled in our first Phase 3 study as subjects for safety evaluation. The protocol would have required enrollment to be suspended after 60 patients had been enrolled. Enrollment to study would continue only once an independent data and safety monitoring board (DSMB) had reviewed the safety data and deemed there were no safety issues," continued Dr. Tagliaferri.

"However, the Agency instead recommended, and we agreed to conduct, a Phase 1 study in advance of the Phase 3 study. The Phase 1 open label trial will enroll 20 postmenopausal women who will all receive Menerba 15g/day (7.5g BID) for 28 days. This approach wil
'/>"/>

SOURCE Bionovo, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Bionovo Announces Positive Developments in On-going Phase 1/2 Cancer Drug Trial
2. Bionovo Announces Publication of the Paper Detailing the Mechanism of Action of Its Cancer Drug BZL101
3. Bionovo Discovers New Estrogen Regulatory Elements for Breast Cancer and Osteoporosis Drugs
4. Bionovos Drug Candidate for Menopausal Symptoms Shows Effect on Neural Pathways Related to Temperature Regulation
5. Bionovo Elucidates Mechanism of Breast Cancer Control by Estrogen Receptor Beta
6. Bionovo Reports on Metabolic Studies Related to Its Menopausal Hot Flash Drug Candidate
7. Bionovos MF101 Shows Statistically Significant Improvement in Sleep Disturbance from Hot Flashes
8. Bionovos VG101 Shows Greater Efficacy Than Estrogen in the Treatment of Vaginal Dryness
9. Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer
10. Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology
11. Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... , June 30, 2015  IGI Laboratories, Inc. ... based specialty generic pharmaceutical company, today announced it ... to the U.S. Food and Drug Administration (FDA) of ... submissions now pending at the FDA to twenty-seven. ... the Company, commented, "We believe our current pipeline of ...
(Date:6/30/2015)... Dipexium Pharmaceuticals, Inc. (Nasdaq: DPRX ... the development and commercialization of Locilex® (pexiganan cream ... announced underwritten public offering of 1,480,000 shares of ... option in full to purchase an additional 222,000 ... proceeds to Dipexium are expected to be approximately ...
(Date:6/30/2015)... 2015  Today, the National Mobility Equipment Dealers Association ... Mobility Awareness Month Local Heroes Contest on National TV. ... that received 1.3 million votes. The sponsors for the ... Mobility , and Valley Honda Dealers , with ... Vantage Mobility International (VMI) and ElDorado Mobility ...
Breaking Medicine Technology:IGI Laboratories, Inc. Announces Fifth ANDA Submission Of 2015 2Dipexium Announces Closing of Public Offering of Common Stock 2Dipexium Announces Closing of Public Offering of Common Stock 3NMEDA Announces National Contest Winners 2NMEDA Announces National Contest Winners 3
... Aug. 2 Novalar Pharmaceuticals, Inc., a specialty pharmaceutical company focused ... again been selected by leading dental industry magazine Dentistry Today as one ... 24th annual competition were published in the July issue.   , ... OraVerse is the first ...
... , ST. LOUIS ,  Aug. 2 K-V Pharmaceutical ... received notification from the New York Stock Exchange ("NYSE") on ... quantitative continued listing standards.  The NYSE informed the Company that ... criteria for the average closing price of a NYSE security ...
Cached Medicine Technology:OraVerse® Named as One of Dentistry Today's 'Top 100 Products' for Second Year 2OraVerse® Named as One of Dentistry Today's 'Top 100 Products' for Second Year 3K-V Pharmaceutical Company Notified by New York Stock Exchange of Non-Compliance With Continued Listing Standards 2K-V Pharmaceutical Company Notified by New York Stock Exchange of Non-Compliance With Continued Listing Standards 3K-V Pharmaceutical Company Notified by New York Stock Exchange of Non-Compliance With Continued Listing Standards 4K-V Pharmaceutical Company Notified by New York Stock Exchange of Non-Compliance With Continued Listing Standards 5K-V Pharmaceutical Company Notified by New York Stock Exchange of Non-Compliance With Continued Listing Standards 6K-V Pharmaceutical Company Notified by New York Stock Exchange of Non-Compliance With Continued Listing Standards 7K-V Pharmaceutical Company Notified by New York Stock Exchange of Non-Compliance With Continued Listing Standards 8K-V Pharmaceutical Company Notified by New York Stock Exchange of Non-Compliance With Continued Listing Standards 9
(Date:6/30/2015)... ... ... Trenton Health Team has been certified by the New Jersey Department of ... State, serving the greater Trenton community. The ACO pilot is for a three-year ... collaborative structure of THT, bringing together the vast majority of Trenton’s primary and specialty ...
(Date:6/30/2015)... ... 2015 , ... Retail Management Solutions is headed out to ... 29 to August 1. Retail Management Solutions will be attending along with pharmacy ... event for independent community pharmacies, where they receive practical and clinical knowledge, helping ...
(Date:6/30/2015)... ... 2015 , ... The American Lung Association in California announced its new partnership ... Speakers and clean air advocates included San Diego County Supervisor Ron Roberts, Dr. Atul ... Daniel Sullivan, founder and president of Sullivan Solar Power. , For every solar ...
(Date:6/30/2015)... ... 30, 2015 , ... University Post-Acute Rehab recently released a ... rehab center’s patients and their experiences at the facility. Medicare granted University Post-Acute ... Each patient attests to the high rating, which is predominantly based on cleanliness, ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... According to ... received a $3.1 million grant to study how sensory stimuli can be used to ... emphasis on improving care for children with autism, will compare patient experience in a ...
Breaking Medicine News(10 mins):Health News:Trenton Health Team Certified as Medicaid Accountable Care Organization 2Health News:Trenton Health Team Certified as Medicaid Accountable Care Organization 3Health News:Retail Management Solutions to Attend Amerisource's ThoughtSpot 2015 Conference and Trade Show 2Health News:Retail Management Solutions to Attend Amerisource's ThoughtSpot 2015 Conference and Trade Show 3Health News:Local Dignitaries Gather to Announce San Diego’s Clean Air Challenge 2Health News:Local Dignitaries Gather to Announce San Diego’s Clean Air Challenge 3Health News:Patients of University Post-Acute Rehab Support Five-Star Rating in New Video 2Health News:New Study Aims to Determine if Sensory Stimuli can Ease Dental Anxiety in Children, Notes Medical Center Dental Care 2Health News:New Study Aims to Determine if Sensory Stimuli can Ease Dental Anxiety in Children, Notes Medical Center Dental Care 3
... housework and even though the housewife who does it is ... cancer. ,A research that surveyed 200,000 women from ... protective than playing sport. ,It has been long ... perhaps through hormonal and metabolic changes. ,Dusting, mopping ...
... War between scientists and bacteria has been going on for ... hand when they come up with a new anti-biotic that// ... celebrations are still going on, different resistant strains make an ... seems that a team of scientists at the Weizmann Institute ...
... risk factor for cardiovascular diseases.,A potbelly indicates that the risk ... of the body is skinny as a beanpole. ... is the relationship of waist size to the hips, an ... ,The study implies that even people who would otherwise be ...
... begun. Breakfast may soon be trimmings of cloned pig’s bacon, a ... beef or goat burger; ‘Frankenstein foods’, as some// refer to it. ... Administration (FDA) of US is getting ready to pass a bill ... our decision on looking at the health of the animal,” says ...
... in 2002, at the San Francisco's 2002 Gay Pride, San ... to popularize syphilis testing. ,In the above said ... to Gayville, encouraging the many hundreds of homo whores who ... (Syphilis) ,Although many were not happy with the ...
... company claimed to have developed a weight reduction pill, which ... cut the risk of heart disease, diabetes and cancer. ... 10 percent when taken for a year. ,But ... Californian biopharmaceutical firm Orexigen for 48 weeks lost 12 percent ...
Cached Medicine News:Health News:Household Chores May Reduce Risk Of Breast Cancer 2Health News:Scientists Come Up With A Powerful Weapon To Fight Drug Resistant Bacteria 2Health News:Pot Belly Is A Better Risk Predictor Of Heart Attack Than BMI 2Health News:Clones On the Menu 2
... The MicroAire® Hi Speed Pulse Lavage ... bone surfaces as well as cleansing ... Now a great system just got ... effective with the addition of ...
... Staple is a novel shape memory alloy bone ... of its Nitinol construction, the prongs of the ... upon application of a heating current. This results ... response of bone and cause adjustable compression across ...
... deformity of the ankle joint with ... fusion of the ankle joint, fractures ... where reconstruction is impossible, and fracture/dislocations ... severe arthritic changes and loss of ...
The Buechel-pappas™ Total Ankle Replacement is a time-tested system which is the result of more than twenty years of development, clinical investigation, and use. The components have been avai...
Medicine Products: